HuGE Literature Finder
Records
1
-
30
| Genomic Profiling Identified Prognostic Biomarkers of Definitive Chemo-Radiotherapy Response in Esophageal Carcinoma. International journal of radiation oncology, biology, physics 2021 Nov 111 (3S): S13. Li L, Yuan S, Sun J, Yin Y, Cui J, Zhang J, Chen Y, Pang J, Yin J, Shao Y, Yu |
| Clinical utility of testing for PALB2 and CHEK2 c.1100delC in breast and ovarian cancer. Genetics in medicine : official journal of the American College of Medical Genetics 2021 Jun . Woodward Emma R, van Veen Elke M, Forde Claire, Harkness Elaine F, Byers Helen J, Ellingford Jamie M, Burghel George J, Schlech Helene, Bowers Naomi L, Wallace Andrew J, Howell Sacha J, Howell Anthony, Lalloo Fiona, Newman William G, Smith Miriam J, Gareth Evans |
| A pathogenic variant in CHEK2 shows a founder effect in Portuguese Roma patients with thyroid cancer. Endocrine 2021 Mar . Pires Carolina, Marques Inês Jorge, Dias Daniela, Saramago Ana, Leite Valeriano, Cavaco Branca Mar |
| Genetic Profiles of Aggressive Variants of Papillary Thyroid Carcinomas. Cancers 2021 Feb 13 (4): . Jin Meihua, Song Dong Eun, Ahn Jonghwa, Song Eyun, Lee Yu-Mi, Sung Tae-Yon, Kim Tae Yong, Kim Won Bae, Shong Young Kee, Jeon Min Ji, Kim Won |
| Homologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancer. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2021 Jan . Lotan Tamara L, Kaur Harsimar B, Salles Daniela C, Murali Sanjana, Schaeffer Edward M, Lanchbury Jerry S, Isaacs William B, Brown Robert, Richardson Andrea L, Cussenot Olivier, Cancel-Tassin Geraldine, Timms Kirsten M, Antonarakis Emmanuel |
| Mutation profile of non-small cell lung cancer revealed by next generation sequencing. Respiratory research 2021 Jan 22 (1): 3. Chang Ya-Sian, Tu Siang-Jyun, Chen Yu-Chia, Liu Ting-Yuan, Lee Ya-Ting, Yen Ju-Chen, Fang Hsin-Yuan, Chang Jan-Gow |
| Survival of bladder or renal cancer in patients with CHEK2 mutations. PloS one 2021 16 (9): e0257132. Z?owocka-Per?owska El?bieta, D?bniak Tadeusz, S?ojewski Marcin, van de Wetering Thierry, To?oczko-Grabarek Aleksandra, Cybulski Cezary, Scott Rodney J, Lubi?ski J |
| Pathogenic germline variants in patients with features of hereditary renal cell carcinoma: Evidence for further locus heterogeneity. Genes, chromosomes & cancer 2020 Aug . Smith Philip S, West Hannah, Whitworth James, Castle Bruce, Sansbury Francis H, Warren Anne Y, Woodward Emma R, Tischkowitz Marc, Maher Eamonn |
| Cumulative Evidence for Associations between Genetic Variants and Risk of Esophageal Cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2020 Jan . Li Gaoming, Song Qiuyue, Jiang Yuxing, Cai Angsong, Tang Yong, Tang Ning, Yi Dali, Zhang Rui, Wei Zeliang, Liu Dingxin, Chen Jia, Zhang Yanqi, Liu Ling, Wu Yazhou, Zhang Ben, Yi Do |
| The Coexistence of Genetic Mutations in Thyroid Carcinoma Predicts Histopathological Factors Associated With a Poor Prognosis: A Systematic Review and Network Meta-Analysis. Frontiers in oncology 2020 10 540238. Zhao Ling, Wang Lin, Jia Xiaomeng, Hu Xiaodong, Pang Ping, Zhao Sitong, Wang Yajing, Wang Jing, Zhang Yingshi, Lyu Zhaoh |
| Frequency of Pathogenic Germline Variants in CDH1, BRCA2, CHEK2, PALB2, BRCA1, and TP53 in Sporadic Lobular Breast Cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2019 Jul 28 (7): 1162-1168. Petridis Christos, Arora Iteeka, Shah Vandna, Moss Charlotte L, Mera Anca, Clifford Angela, Gillett Cheryl, Pinder Sarah E, Tomlinson Ian, Roylance Rebecca, Simpson Michael A, Sawyer Elinor |
| Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50?years. Breast cancer research : BCR 2019 May 21 (1): 58. Petridis Christos, Arora Iteeka, Shah Vandna, Megalios Anargyros, Moss Charlotte, Mera Anca, Clifford Angela, Gillett Cheryl, Pinder Sarah E, Tomlinson Ian, Roylance Rebecca, Simpson Michael A, Sawyer Elinor |
| Association of genetic variants in CHEK2 with oesophageal squamous cell carcinoma in the South African Black population. Carcinogenesis 2019 Feb . Chen Wenlong C, Bye Hannah, Matejcic Marco, Amar Ariella, Govender Dhiren, Khew Yee Wen, Beynon Victoria, Kerr Robyn, Singh Elvira, Prescott Natalie J, Lewis Cathryn M, Babb de Villiers Chantal, Parker M Iqbal, Mathew Christopher |
| The clinical importance of BRCAness in a population-based cohort of Danish epithelial ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2019 Jan 29 (1): 166-173. Hjortkjær Mette, Malik Aagaard Jørgensen Mads, Waldstrøm Marianne, Ørnskov Dorthe, Søgaard-Andersen Erik, Jakobsen Anders, Dahl-Steffensen Kari |
| High-risk epithelial ovarian cancer patients for hereditary ovarian cancer. The journal of obstetrics and gynaecology research 2017 Feb . Chirasophon Seksit, Manchana Tarinee, Teerapakpinyo Chinacho |
| Germline multi-gene hereditary cancer panel testing in an unselected endometrial cancer cohort. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016 Nov 29 (11): 1381-1389. Ring Kari L, Bruegl Amanda S, Allen Brian A, Elkin Eric P, Singh Nanda, Hartman Anne-Renee, Daniels Molly S, Broaddus Russell |
| Novel Nonsense Variants c.58C>T (p.Q20X) and c.256G>T (p.E85X) in the CHEK2 Gene Identified in Breast Cancer Patients from Balochistan. Asian Pacific journal of cancer prevention : APJCP 2016 17 (7): 3623-6. Baloch Abdul Hameed, Khosa Ahmad Nawaz, Bangulzai Nasrullah, Shuja Jamila, Naseeb Hafiz Khush, Jan Mohammad, Marghazani Illahi Bakhsh, Kakar MasoodulHaq, Baloch Dost Mohammad, Cheema Abdul Majeed, Ahmad Jam |
| Rare variants in BRCA2 and CHEK2 are associated with the risk of urinary tract cancers. Scientific reports 2016 6 33542. Ge Yuqiu, Wang Yunyan, Shao Wei, Jin Jing, Du Mulong, Ma Gaoxiang, Chu Haiyan, Wang Meilin, Zhang Zhengdo |
| Subtyping sub-Saharan esophageal squamous cell carcinoma by comprehensive molecular analysis. JCI insight 2016 10 1 (16): e88755. Liu Wenjin, Snell Jeff M, Jeck William R, Hoadley Katherine A, Wilkerson Matthew D, Parker Joel S, Patel Nirali, Mlombe Yohannie B, Mulima Gift, Liomba N George, Wolf Lindsey L, Shores Carol G, Gopal Satish, Sharpless Norman |
| Contribution of rare germline copy number variations and common susceptibility loci in Lynch syndrome patients negative for mutations in the mismatch repair genes. International journal of cancer. Journal international du cancer 2015 Dec . Villacis Rolando A R, Miranda Priscila M, Gomy Israel, Santos Erika M M, Carraro Dirce M, Achatz Maria I, Rossi Benedito M, Rogatto Silvia |
| Impact of alcohol dehydrogenase gene 4 polymorphisms on esophageal squamous cell carcinoma risk in a Chinese population. PloS one 2015 10 (6): e0127304. Xu Xiaoling, Wang Jiwen, Zhu Shuang-Mei, Yang Ming, Fang Yun, Zhao An, Song Qian, Mao Weim |
| The c.470 T?>?C CHEK2 missense variant increases the risk of differentiated thyroid carcinoma in the Great Poland population. Hereditary cancer in clinical practice 2015 13 (1): 8. Kaczmarek-Ry? Marta, Ziemnicka Katarzyna, Hryhorowicz Szymon T, Górczak Katarzyna, Hoppe-Go??biewska Justyna, Skrzypczak-Zieli?ska Marzena, Tomys Michalina, Go??b Monika, Szkudlarek Malgorzata, Budny Bart?omiej, Siatkowski Idzi, Gut Pawe?, Rucha?a Marek, S?omski Ryszard, P?awski Andrz |
| Variants in the ATM-CHEK2-BRCA1 axis determine genetic predisposition and clinical presentation of papillary thyroid carcinoma. Genes, chromosomes & cancer 2014 Jun 53 (6): 516-23. Wójcicka Anna, Czetwerty?ska Ma?gorzata, ?wierniak Micha?, D?ugosi?ska Joanna, Maci?g Monika, Czajka Agnieszka, Dymecka Kinga, Kubiak Anna, Kot Adam, P?oski Rafa?, de la Chapelle Albert, Ja?d?ewski Krysti |
| Identification of two poorly prognosed ovarian carcinoma subtypes associated with CHEK2 germ-line mutation and non-CHEK2 somatic mutation gene signatures. Cell cycle (Georgetown, Tex.) 2014 13 (14): 2262-80. Ow Ghim Siong, Ivshina Anna V, Fuentes Gloria, Kuznetsov Vladimir |
| Lack of CHEK2 gene mutations in differentiated thyroid carcinoma patients using high resolution melting analysis. Asian Pacific journal of cancer prevention : APJCP 2014 15 (12): 5019-22. Fayaz Shima, Fard-Esfahani Pezhman, Torbati Peyman Mohamma |
| Genetic variants in DNA repair pathway genes and risk of esophageal squamous cell carcinoma and gastric adenocarcinoma in a Chinese population. Carcinogenesis 2013 Jul 34 (7): 1536-42. Li Wen-Qing, Hu Nan, Hyland Paula L, Gao Ying, Wang Zhao-Ming, Yu Kai, Su Hua, Wang Chao-Yu, Wang Le-Min, Chanock Stephen J, Burdett Laurie, Ding Ti, Qiao You-Lin, Fan Jin-Hu, Wang Yuan, Xu Yi, Shi Jian-Xin, Gu Fangyi, Wheeler William, Xiong Xiao-Qin, Giffen Carol, Tucker Margaret A, Dawsey Sanford M, Freedman Neal D, Abnet Christian C, Goldstein Alisa M, Taylor Philip |
| BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma. Cancer 2013 Jan 119 (2): 332-8. Pennington Kathryn P, Walsh Tom, Lee Ming, Pennil Christopher, Novetsky Akiva P, Agnew Kathy J, Thornton Anne, Garcia Rochelle, Mutch David, King Mary-Claire, Goodfellow Paul, Swisher Elizabeth |
| Concomitance of oncogenic HPV types, CHEK2 gene mutations, and CYP1B1 gene polymorphism as an increased risk factor for malignancy. Central European journal of urology 2013 66 (1): 23-9. Banaszkiewicz Monika, Constantinou Maria, Pietrusi?ski Micha?, K?pczy?ski Lukasz, J?drzejczyk Adam, Ro?niecki Marek, Marks Piotr, Ka?u?ewski Bogd |
Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls.
Human molecular genetics 2012 Nov 21 (22): 4980-95. Timofeeva Maria N, Hung Rayjean J, Rafnar Thorunn, Christiani David C, Field John K, Bickeböller Heike, Risch Angela, McKay James D, Wang Yufei, Dai Juncheng, Gaborieau Valerie, McLaughlin John, Brenner Darren, Narod Steven A, Caporaso Neil E, Albanes Demetrius, Thun Michael, Eisen Timothy, Wichmann H-Erich, Rosenberger Albert, Han Younghun, Chen Wei, Zhu Dakai, Spitz Margaret, Wu Xifeng, Pande Mala, Zhao Yang, Zaridze David, Szeszenia-Dabrowska Neonilia, Lissowska Jolanta, Rudnai Peter, Fabianova Eleonora, Mates Dana, Bencko Vladimir, Foretova Lenka, Janout Vladimir, Krokan Hans E, Gabrielsen Maiken Elvestad, Skorpen Frank, Vatten Lars, Njølstad Inger, Chen Chu, Goodman Gary, Lathrop Mark, Benhamou Simone, Vooder Tõnu, Välk Kristjan, Nelis Mari, Metspalu Andres, Raji Olaide, Chen Ying, Gosney John, Liloglou Triantafillos, Muley Thomas, Dienemann Hendrik, Thorleifsson Gudmar, Shen Hongbing, Stefansson Kari, Brennan Paul, Amos Christopher I, Houlston Richard, Landi Maria Teresa, |
| CHEK2 gene alterations independently increase the risk of death from breast cancer in Bulgarian patients. Neoplasma 2012 59 (6): 622-30. Angelova S G, Krasteva M E, Gospodinova Z I, Georgieva E |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 28, 2022
- Content source: